Triptolide impedes high glucose-induced cell function in HK2 cells through PRKN-mediated ubiquitination of ACSL1
Journal of Endocrinology · 01.12.2025 · 267 (3)
DOI: 10.1530/joe-25-0095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, online erschienen am 26.11.2025. Verfasst von Jiangsong Jia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Henan Provincial People's Hospital; People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzh…. Hauptthemen laut MEDLINE: Coenzyme A Ligases, Glucose, Phenanthrenes, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Graphical abstract Abstract Triptolide (TP), a bioactive compound, demonstrates efficacy in ameliorating diabetic nephropathy (DN). This study aimed to investigate the role of TP in renal tubular injury during DN and elucidate the underlying mechanism involving acyl-CoA synthetase long-chain family member 1 (ACSL1) and parkin (PRKN). The DN model was induced in HK2 cells by high glucose (HG, 30 mmol/L). Cell counting kit-8, EdU assay, and flow cytometry were used to assess cell viability, proliferation, and apoptosis. Inflammatory cytokines were measured via enzyme-linked immunosorbent assay. Ferroptosis was assessed by detecting reactive oxygen species, lipid peroxidation (MDA), Fe2+, and glutathione (GSH) using kits. The mRNA and protein examinations were performed by real-time quantitative PCR and western blotting. Co-immunoprecipitation assay was conducted for protein interaction and ubiquitination detection. DN in mice was established by high-fat diet and streptozocin injection. The effects of TP on mice were analyzed by histopathology analysis, biochemical analysis, and protein detection. TP mitigated HG-induced apoptosis, inflammation, and ferroptosis in HK2 cells. The protective effects of TP against HG-induced injury in HK2 cells were mediated by the inhibition of ACSL1. PRKN promoted ubiquitination of ACSL1 to reduce the protein level of ACSL1. PRKN/ACSL1 inhibited HG-induced HK2 cell dysfunction. The protective effect of TP in HG-stimulated HK2 cells was mediated by the upregulation of PRKN. TP activated the anti-ferroptosis NRF2/SLC7A11/GPX4 pathway by targeting ACSL1. TP could ameliorate kidney injury in DN mice through modulating PRKN, ACSL1, and the NRF2/SLC7A11/GPX4 pathway. All these discoveries suggested that TP protected HK2 cells from HG-triggered kidney injury through upregulating PRKN, which further promoted ubiquitination of ACSL1. Highlights Triptolide prevents apoptosis, inflammation, and ferroptosis in HG-induced HK2 cells via downregulating ACSL1. PRKN induces the ubiquitination of ACSL1 to alleviate HG-induced HK2 cell injury. Knockdown of PRKN inhibits the function of triptolide in HG-treated HK2 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Henan Provincial People's Hospital; People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, China.
- Department of General Practice, Henan Provincial People's Hospital; People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, China.
ORCID-Profile: Jun Sun
Zitieren
APA
Jia, J., Zhao, W. M., Wang, X., Guo, M., & Sun, J. (2025). Triptolide impedes high glucose-induced cell function in HK2 cells through PRKN-mediated ubiquitination of ACSL1. Journal of Endocrinology, 267(3). https://doi.org/10.1530/joe-25-0095
Vancouver
Jia J, Zhao WM, Wang X, Guo M, Sun J. Triptolide impedes high glucose-induced cell function in HK2 cells through PRKN-mediated ubiquitination of ACSL1. Journal of Endocrinology. 2025;267(3). doi:10.1530/joe-25-0095
BibTeX
@article{Jia2025,
author = {Jia, Jiangsong and Zhao, Wen-Ming and Wang, Xin and Guo, Meishan and Sun, Jun},
title = {Triptolide impedes high glucose-induced cell function in HK2 cells through PRKN-mediated ubiquitination of ACSL1},
journal = {Journal of Endocrinology},
year = {2025},
volume = {267},
number = {3},
doi = {10.1530/joe-25-0095}
}
EUVIMED